Analytic Investors’s Medtronic MDT Stock Holding History

Analytic Investors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-20,425	Closed	-$1.77M	–	644
2016 Q2	$1.77M	Sell	20,425 -61,962	-75%	-$5.01M	0.02%	291
2016 Q1	$6.18M	Buy	82,387 +79,615	+2,872%	+$6M	0.08%	182
2015 Q4	$213K	Sell	2,772 -2,448	-47%	-$184K	﹤0.01%	600
2015 Q3	$349K	Sell	5,220 -224,209	-98%	-$16.5M	﹤0.01%	488
2015 Q2	$17M	Buy	229,429 +218,948	+2,089%	+$16.7M	0.24%	99
2015 Q1	$817K	Buy	+10,481	New	+$794K	0.01%	391
2014 Q2	–	Sell	-127,242	Closed	-$7.83M	–	564
2014 Q1	$7.83M	Buy	127,242 +22,251	+21%	+$1.3M	0.12%	154
2013 Q4	$6.03M	Buy	+104,991	New	+$5.95M	0.1%	163
2013 Q3	–	Sell	-11,095	Closed	-$571K	–	547
2013 Q2	$571K	Buy	+11,095	New	+$548K	0.01%	419

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Analytic Investors's MDT Position: Q3 2016 in Review

Analytic Investors sold out of Medtronic (MDT) in Q3 2016, closing a stake of 20,425 shares — an estimated $1.77M sold.

Analytic Investors first reported a position in MDT in Q2 2013 and held it in 9 quarters. The position peaked at $17M in Q2 2015. 1,266 funds tracked by Wall St. Rank hold MDT as of Q3 2016.

Analytic Investors reported no remaining Medtronic position as of Q3 2016 after selling out during the quarter.
Analytic Investors sold 20,425 Medtronic shares in Q3 2016, an estimated $1.77M.
Analytic Investors first reported a position in Medtronic in Q2 2013 and held it in 9 quarters.
Analytic Investors's Medtronic position peaked at $17M in Q2 2015.
1,266 funds tracked by Wall St. Rank held Medtronic as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.